Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OXAZEPAM vs OXYBUTYNIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OXAZEPAM vs OXYBUTYNIN: Safety Overview

Metric OXAZEPAM OXYBUTYNIN
Total FAERS Reports 12,440 7,784
Deaths Reported 2,965 350
Death Rate 23.8% 4.5%
Hospitalizations 6,242 1,113
Average Patient Age 57.3 yrs 62.0 yrs
% Female Patients 58.3% 80.1%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Aphena Pharma Solutions - Tennessee, LLC Aphena Pharma Solutions - Tennessee, LLC
Route ORAL ORAL
Marketing Status Discontinued Discontinued